Stay updated on Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T17:07:11.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T18:06:30.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    403 Forbidden page is now shown, replacing the study record content. The main study details become inaccessible on this page, limiting user access to information about the trial.
    Difference
    19%
    Check dated 2026-09-19T19:22:12.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Removed the term Melanoma from the study's condition labeling and deleted the related topics section header and the MedlinePlus Genetics link, reducing explicit condition labeling and related-topic navigation without altering the study design or outcomes.
    Difference
    0.2%
    Check dated 2026-09-12T19:12:18.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Melanoma and related topics: MedlinePlus Genetics were added under related topics to improve navigation and indexing. There were no deletions.
    Difference
    0.2%
    Check dated 2026-09-05T19:49:52.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a new release tag for the page. This update is a minor version bump with no substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-29T20:24:44.000Z thumbnail image

Stay in the know with updates to Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.